These effects, together with a prior report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 support the notion of concentrating on ACKR3 as a novel strategy to modulate the opioid program, which could open up new therapeutic avenues for opioid-similar Diseases. The similarity among a https://raymondh260vsq0.wikigop.com/user